Abstract:Abstract There is evidence from epidemiologic data that cataract is more common in women than men. This is not solely due to a higher rate of cataract extraction in women, as is the case in the western world, but several population-based studies show that females have a higher prevalence of lens opacities, especially cortical. There is no firm evidence that lifestyle-related factors are the cause of this gender discrepancy. Focus has therefore been directed towards the role of estrogen in cataract formation. Although data on endogenous and exogenous estrogen involvement in cataractogenesis are conflicting, some studies have indicated that hormone therapy may decrease the risk of cataract and thus be protective. It has been hypothesized that the decrease in estrogen at menopause cause increased risk of cataract in women, i.e. not strictly the concentration of estrogen, but more the withdrawal effect. Estrogens are known to exert several anti-aging effects that may explain the longer lifespan in women, including metabolically beneficial effects, neuroprotection, preservation of telomeres and anti-oxidative properties. Since oxidative stress is considered important in cataractogenesis, studies have investigated the effects of estrogens on lens epithelial cells in culture or in animal models. Several investigators have found protection by physiological concentrations of 17β-estradiol against oxidative stress induced by H2O2 in cultured lens epithelial cells. Although both main types of estrogen receptors, ERα and ERβ, have been demonstrated in lens epithelium, most studies so far indicate that the estrogen-mediated protection in the lens is exerted through non-genomic, i.e. receptor-independent mechanisms, possibly through phosphorylation of extracellular signal-regulated kinase (ERK1/ERK2), a member of the mitogen-activated protein kinase (MAPK)-signaling pathway. Further studies are needed, both epidemiologic as to the role of hormone therapies, and laboratory studies regarding molecular estrogen-mediated mechanisms, in order to comprehend the role of estrogens on cataract formation.

Novel Identification of a Four-base-pair Deletion Mutation Inpitx2in a Rieger Syndrome Family

Identification of A Novel Frameshift Mutation in Pitx2 Gene in A Chinese Family with Axenfeld-Rieger Syndrome

Identification of human dental follicle cells with RUNX2 gene mutation

A Novel 4q25 Microdeletion Encompassing PITX2 Associated with Rieger Syndrome

Novel PITX2 Mutations Identified in Axenfeld-Rieger Syndrome and the Pattern of PITX2-related Tooth Agenesis.

[Analysis of RECQL4 Gene Variant in a Child with Rothmund-Thomson Syndrome].

Deletion of exon 4 of the PITX2 in a child with Axenfeld–Rieger syndrome

Enamel Defects of Axenfeld-Rieger Syndrome and the Role of PITX2 in Its Pathogenesis

Identification and functional study of a novel variant of PAX9 causing tooth agenesis

Identification and functional analysis of two novel PAX9 mutations.

Novel PAX9 and COL1A2 missense mutations causing tooth agenesis and OI/DGI without skeletal abnormalities

Novel frameshift Variant c.3056delA of the DHX38 Gene in a Chinese Family With Retinitis Pigmentosa

Gender and Cataract – The Role of Estrogen

A novel initiation codon mutation of PAX9 in a family with oligodontia

Identification of Two Novel Mutations of DSPP Gene in Dentinogenesis Imperfecta Type II

Identification of a Novel Frameshift Variant of POU3F4 and Genetic Counseling of Korean Incomplete Partition Type III Subjects Based on Detailed Genotypes

A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets

Complex balanced intrachromosomal rearrangement involving PITX2 identified as a cause of Axenfeld‐Rieger Syndrome

Novel PAX9 Mutations Causing Isolated Oligodontia

Non-syndromic oligodontia with a novel mutation of PAX9

In Silico Characterization of Pathogenic Homeodomain Missense Mutations in the PITX2 Gene